Abstract

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in the oral mucosa. Pathological biopsy is still the current gold standard for OSCC diagnosis; however, some drawbacks need to be overcome. Therefore, it is urgently needed to find a non-invasive targeted technology for OSCC early diagnosis. Fluorescent optical imaging using near infrared (NIR) dyes tagged to tumor specific target will benefit such developments. Gastrin releasing peptide receptor (GRPR) is an attractive target for OSCC imaging and therapy. In this study, we synthesized nano-graphene oxide (NGO) nanoparticles with GRPR-specific peptides AF750-6Ahx-Sta-BBN via hydrogen bond and π–π bonds (NGO-BBN-AF750), and investigated their receptor binding, cell uptake and internalization in HSC-3 cells. NGO-BBN-AF750 and AF750-6Ahx-Sta-BBN showed a similar binding affinity to GRPR on HSC-3 cells. In contrast to AF750-6Ahx-Sta-BBN antagonist peptide, NGO-BBN-AF750 showed cellular internalization property. Overall, this study proposes a NGO nanoclusters-based nanoprobe for GRPR targeted near-infrared fluorescence imaging for OSCC. Nanoparticle-based delivery systems have shown highly significant potential in the delivery of a wide range of therapeutic agents.

Highlights

  • Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in the oral mucosa

  • Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in the head and ­neck[1]

  • Lango ­MN13 found that Gastrin releasing peptide receptor (GRPR) is overexpressed in both head and neck squamous cell carcinoma (HNSCC) tumors and adjacent normal mucosa from HNSCC patients compared with levels in control mucosa from individuals without cancer

Read more

Summary

Introduction

Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in the oral mucosa. Fluorescent optical imaging using near infrared (NIR) dyes tagged to tumor specific target will benefit such developments. Oral squamous cell carcinoma (OSCC) is the most common malignant tumor that occurs in the head and ­neck[1]. Lango ­MN13 found that GRPR is overexpressed in both head and neck squamous cell carcinoma (HNSCC) tumors and adjacent normal mucosa from HNSCC patients compared with levels in control mucosa from individuals without cancer. Bombesin (BBN) peptide has shown high binding affinity and specificity to target the GRPR; efforts have been focused on developing radiolabeled or fluorescent dye labeled BBN analogues for tumor imaging and t­ herapy[14,16,17,18,19]. Nano-graphene oxide (NGO) has a characteristic of large surface area, good water dispersibility and biocompatibility, facile surface modification, and low manufacturing cost, making it a promising candidate for biological a­ pplications[26]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call